Dr. Tai-Chung Lam graduated from The University of Hong Kong in 2003 and joined the Department of Clinical Oncology in Tuen Mun Hospital in 2005. He joined the Department of Clinical Oncology, LKS Faculty of Medicine HKU in Feb 2016. He had received overseas training stereotactic radiation therapy in Germany. He was also the clinical fellow of the Harvard School of Medicine in 2013-14.
His research interests include cancers of the central nervous system, stereotactic radiation therapy for brain and spinal tumors, as well as palliative care in advanced cancer patients. He is also participating in molecular tumor board for precision oncology services and runs investigator-initiated clinical trials.
- Use of advanced radiotherapy technique for brain and spinal metastases
- Early palliative care to address psycho-spiritual needs of advanced cancer patients
- Biomarkers for cancer immunotherapies
• Tai-Chung Lam, Arjun Sahgal , Eric L Chang , Simon S Lo. Stereotactic Radiosurgery for Multiple Brain metastases. Expert Review of Anticancer Therapy October 2014, Vol. 14, No. 10 : Pages 1153- 1172
• Matthew D. Cheney, Tai-Chung Lam, Hajime Uno, Barbara A. Jaehn, Antonio L. Damato, Monica S. Krishnan, Tracy A. Balboni. Outcomes after palliative re-irradiation of spinal metastases. Journal of Radiation Oncology June 2015, Volume 4, Issue 2, pp 157-162
• Tai-Chung Lam, Hajime Uno, Monica Krishnan, Steven Lutz, Michael Groff, Matthew Cheney, Tracy Balboni. Adverse Outcomes after Palliative Radiation Therapy for Uncomplicated Spine Metastases: Role of Spinal Instability and Single Fraction Radiation Therapy. Internation Journal of Radiation Oncology. Biology. Physics. 2015 Jun 9. Vol. 93
• Tai-Chung Lam, Tracy A. Balboni, Michael Balboni, Holly G. Prigerson. Differences between patient and caregiver ratings of advanced cancer Patient's quality of life and correlates of their disagreement. ASCO Annual Meeting 2014 abstract presentation.
• Tai-Chung Lam, Tracy A. Balboni, Michael Balboni, Holly G. Prigerson. Spirituality and quality of life among caregivers of advanced cancer patients.ASCO Annual Meeting 2014 abstract presentation